Extracellular serine protease
View Patent ↗The present invention provides a DNA encoding a TADG-14 protein selected from the group consisting of: (a) isolated DNA which encodes a TADG-14 protein; (b) isolated DNA which hybridizes to isolated DNA of (a) above and which encodes a TADG-14 protein; and (c) isolated DNA differing from the isolated DNAs of (a) and (b) above in codon sequence due to the degeneracy of the genetic code, and which encodes a TADG-14 protein. Also provided is a vector capable of expressing the DNA of the present invention adapted for expression in a recombinant cell and regulatory elements necessary for expression of the DNA in the cell.
1. A method for diagnosing cancer in an individual, comprising:
detecting Tumor Antigen Derived Gene-14 (TADG-14) mRNA encoding a TADG-14 protein of SEQ ID NO: 7 in a biological sample of an individual, wherein the presence of TADG-14 mRNA indicates the individual has a cancer.
2. The method of claim 1 , wherein detecting TADG-14 comprises:
contacting mRNA present within cells or tissue comprising the biological sample with a labeled hybridization probe having a sequence complementary to a DNA encoding TADG-14 protein or a fragment of said DNA; and
determining if said labeled hybridization probe hybridizes with mRNA via detection of the label.
3. The method of claim 2 , wherein said DNA encoding TADG-14 protein has the sequence shown in SEQ ID No. 6.
4. A method for diagnosing cancer in an individual, comprising:
obtaining a cell or tissue sample from an individual;
contacting mRNA obtained from the cell sample with a labeled hybridization probe having a sequence complementary to a DNA of SEQ ID NO: 6 encoding TADG-14 protein or a fragment of said DNA; and
determining if said labeled hybridization probe hybridizes with the mRNA via detection of the label, wherein the hybridization of the labeled probe to the mRNA is indicative of the presence of a cancer in the individual.
5. The method of claim 4 , wherein said DNA encodes a TADG-14 protein with the amino acid sequence shown in SEQ ID NO: 7.
6. The method of claim 4 , wherein said cancer is ovarian cancer, breast cancer, colon cancer, or prostate cancer.
7. A method for detecting Tumor Antigen Derived Gene-14 (TADG-14) in a biological sample from an individual, comprising:
isolating mRNA from the sample;
synthesizing complementary DNA (cDNA) therefrom;
PCR amplifying the cDNA with primers specific for a TADG-14 DNA of SEQ ID NO: 6 to form an amplified product, thereby detecting the TADG-14 in the sample.
8. The method of claim 7 , wherein the biological sample is blood, cells, tissue, or plasma.
9. The method of claim 7 , wherein the individual has ovarian cancer, breast cancer, colon cancer, or prostate cancer.
10. The method of claim 1 , wherein detecting TADG-14 mRNA comprises PCR, Northern blot or DNA hybridization probes.